BackHemogenyx Pharmaceuticals Plc Overview

Hemogenyx Pharmaceuticals Plc Inventory

Latest inventory for HEMO.L: $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer trimmed avg / median

Loading

Hemogenyx Pharmaceuticals Plc Inventory History

Loading

Hemogenyx Pharmaceuticals Plc vs. peers: Inventory Comparison

Loading

Hemogenyx Pharmaceuticals Plc Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Hemogenyx Pharmaceuticals Plc (HEMO.L) FAQ

Hemogenyx Pharmaceuticals Plc (HEMO.L) currently reports a inventory of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Hemogenyx Pharmaceuticals Plc's inventory history and peer comparisons.

Hemogenyx Pharmaceuticals Plc's inventory changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hemogenyx Pharmaceuticals Plc reported $0 in inventory as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hemogenyx Pharmaceuticals Plc, and consider following HEMO.L for alerts when major investors trade the stock.

Hemogenyx Pharmaceuticals Plc is classified in the Healthcare sector. On inventory, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HEMO.L with unrelated industries.